Advances and Novel Treatment Options in Metastatic Melanoma (Record no. 18710)

MARC details
000 -LEADER
fixed length control field 02097nam a2200133Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220615s9999||||xx |||||||||||||| ||und||
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783040000000
245 #0 - TITLE STATEMENT
Title Advances and Novel Treatment Options in Metastatic Melanoma
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element melanoma||invasion||WNT5A||MARCKS||phosphorylation||MANS peptide||nanoparticles||cell therapy||tumor microenvironment||sex/gender||sex-hormones||immunity||microRNAs||immunotherapy||BRAF-mutant melanoma||BRAF inhibitor||mechanism of action||targeted therapy||tumour microenvironment||plasmacytoid dendritic cells||lactate dehydrogenase||TLR||interferon||CXCL10||TPC2||HIPPO||SOCE||metastasis||essential oils||angiogenesis||apoptosis||uveal melanoma (UM)||metastatic uveal melanoma (mUM)||prognostication||adjuvant therapy||metastatic therapy||metastatic dormancy||liver-directed-therapies||targeted-therapy||combined therapy||protein tyrosine phosphatase||PTPs inhibitors||melanoma immune infiltrate||BRAF inhibitors||microenvironment||resistance||therapy||therapeutic resistance||exosomes||extracellular vesicles||diagnosis||prognosis||ctDNA||liquid biopsy||prediction||patient stratification||BRAF||arthralgia||rheumatoid arthritis||carbonic anhydrase||hedgehog||cyclopamine||small molecules||acetazolamide||motility||metalloproteinases||FAK||cancer||mucosal melanoma||nivolumab||pembrolizumab||ipilimumab||radiotherapy||cholinergic system||acetylcholine||muscarinic receptors||nicotinic receptors||melanoma metastasis||ShcD adaptor protein||amoeboid motility||Rac1||DOCK4||melanoma PDX||target therapy||cancer stem cells||slow cycling phenotype||drug resistance||OXPHOS||lipid metabolism||cancer associated fibroblast||melanomagenesis||biomarkers||checkpoint inhibitor||PD-1||melanoma markers||cytokines||machine learning||Support Vector Machine||principal component analysis||BCL2L10||STAT3||cytotoxicity||survival||ABT-737||Bcl-2 family||ML258||HuR||MITF||metastases||siRNA||n/a
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Facchiano, Antonio||Del Bufalo, Donatella||Carè, Alessandra
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/5029">https://mdpi.com/books/pdfview/book/5029</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 15/06/2022   15/06/2022 15/06/2022 E-Books